XML 23 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net loss $ (174,676,000) $ (65,898,000)
Adjustments to reconcile net loss to net cash provided by operating activities    
Management fees 36,364,000 13,560,000
Performance participation allocation 111,934,000 46,000
Depreciation and amortization 197,934,000 107,993,000
Amortization of deferred financing costs 4,680,000 2,303,000
Straight-line rent amortization (9,331,000) (6,149,000)
Deferred income amortization (3,044,000) (924,000)
Unrealized (gain) loss on changes in fair value of financial instruments (23,288,000) 13,803,000
Foreign currency loss 16,794,000  
Loss on sales of investment in real estate debt   5,789,000
Amortization of restricted stock grants 376,000 80,000
Distributions from investments in unconsolidated real estate ventures 377,000 276,000
Loss from unconsolidated real estate ventures 448,000 887,000
Other items 739,000 25,000
Change in assets and liabilities    
Increase in other assets (23,009,000) (11,837,000)
Increase (decrease) in due to affiliates 748,000 (118,000)
Increase in other liabilities 37,049,000 18,934,000
Net cash provided by operating activities 174,095,000 78,770,000
Cash flows from investing activities    
Acquisitions of real estate (4,540,828,000) (1,891,638,000)
Capital improvements to real estate (21,908,000) (13,678,000)
Investment in unconsolidated real estate ventures (235,000)  
Origination and purchase of investments in real estate debt (801,792,000) (73,188,000)
Purchase of real estate-related equity securities (175,002,000)  
Proceeds from paydown of principal and settlement of investments in real estate debt 41,502,000 111,866,000
Net cash used in investing activities (5,498,263,000) (1,866,638,000)
Cash flows from financing activities    
Proceeds from issuance of common stock, net 3,583,025,000 556,857,000
Offering costs paid (27,996,000) (10,421,000)
Subscriptions received in advance 476,520,000 88,402,000
Repurchase of common stock (39,789,000) (28,462,000)
Borrowings from mortgage notes and revolving credit facility 2,555,679,000 1,251,843,000
Repayments of mortgage notes and revolving credit facility (222,111,000) (1,628,000)
Repayments under secured financings on investments in real estate debt, short term net (42,557,000) (81,035,000)
Borrowings under secured financings on investments in real estate debt 140,150,000 114,408,000
Repayments under secured financings on investments in real estate debt (65,697,000)  
Payment of deferred financing costs (26,253,000) (7,569,000)
Contributions from non-controlling interests 3,537,000 60,192,000
Distributions to non-controlling interests (909,000) (1,556,000)
Repurchase of non-controlling interests   (58,837,000)
Distributions (68,532,000) (24,788,000)
Net cash provided by financing activities 6,265,067,000 1,857,406,000
Net change in cash and cash equivalents and restricted cash 940,899,000 69,538,000
Cash and cash equivalents and restricted cash at the beginning of the period 293,411,000 188,961,000
Cash and cash equivalents and restricted cash at the end of the period 1,234,310,000 258,499,000
Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 671,683,000 132,342,000
Restricted cash 562,627,000 126,157,000
Cash and cash equivalents and restricted cash at the end of the period 1,234,310,000 258,499,000
Supplemental disclosure of cash flow information:    
Cash paid for interest 77,041,000 48,011,000
Supplemental disclosure of non-cash investing and financing activities:    
Assumption of mortgage notes in conjunction with acquisitions in real estate 156,515,000  
Accrued stockholder servicing fee due to affiliate 165,508,000 26,383,000
Right of use asset/liability   6,408,000
Redeemable non-controlling interest issued as settlement for performance participation allocation 15,061,000 10,366,000
Accrued distributions 24,756,000 7,350,000
Distribution reinvestment 58,373,000 29,314,000
Allocation to redeemable non-controlling interest $ 5,556,000 $ 792,000